Warsh Removes Cutting Bias, Signals Possible Hike

Warsh Delivers a Hawkish Shock at His First Meeting

Kevin Warsh's debut as Federal Reserve Chairman produced the macro event markets had been quietly dreading: the FOMC held rates steady but stripped the prior statement language signaling a cutting bias, and multiple officials indicated a rate hike remains on the table for 2026. Jeffrey Gundlach summarized the read-through immediately — Warsh is not the "easy money" chairman many had hoped for. The 2-year Treasury yield rocketed higher in the most precise near-term signal of how far the revised stance shifted the probability distribution around the rate path.

The equity response was decisive. SPY fell 1.25% to $740.96, breaking below its 20-day moving average ($746.80). QQQ dropped 1.01% to $722.51, also slipping under SMA20 ($725.50). XLK finished at $185.80, fractionally below its SMA20 of $186.04 — the exact threshold the portfolio thesis had flagged as the trigger for immediate reassessment. VIX moved from 16.41 to 18.44: not a panic reading, but a clear signal that the market is repricing the forward distribution, not merely absorbing a news release. GLD fell 2.27%, consistent with a real-rate shock compressing the appeal of non-yielding assets.

JPM: The Only Position That Worked

Amid the broad-based selling, JPMorgan Chase posted a +0.70% gain to $333.46 — the only positive return in the candidate universe. The mechanism is direct: removing the cutting bias and introducing rate hike optionality expands net interest income for the most rate-sensitive large commercial bank in the country. JPM's momentum20 of +7.81% and momentum60 of +9.04% are the strongest readings in the universe, and the stock trades 7.8% above its 20-day moving average, confirming a well-established uptrend that today's hawkish catalyst reinforces rather than disrupts.

The position is tripled from 5% to 15%, equaling LLY as the portfolio's highest-weight holding. This is the magnitude of response warranted when the primary fundamental catalyst for a position shifts from likely to confirmed.

Tech Trimmed on Technical Breaches and Macro Regime Change

Both XLK and QQQ crossed below their respective SMA20 levels today — a condition the portfolio thesis explicitly identified as requiring reassessment. The Fed hawkish pivot adds a structural dimension to what might otherwise be read as a single-day technical event: higher discount rates compress the present value of long-duration tech earnings, and removing the cutting bias sustains that pressure into the medium term.

XLK is trimmed from 15% to 10%. The 60-day momentum of +12.64% remains the highest reading in the entire candidate universe — a fact that prevents a full exit and distinguishes this from a broken thesis. Technical discipline requires acknowledging the breach; momentum discipline prevents overreacting to it. QQQ is trimmed from 15% to 10% on identical logic: 60-day momentum of +7.53% is still the third-strongest reading in the universe, and Bridgewater's combined broad-index posture signals that institutional capital does not exit growth compounders on single-day SMA20 breaks. These are trims on changed conditions, not exits on broken theses.

Unchanged Positions: LLY, XLV, NVDA

LLY held at 15%. The stock closed at $1,112.00, maintaining $8.26 of cushion above SMA20 ($1,103.74), and 60-day momentum of +12.02% is the strongest sustained uptrend in the universe. GLP-1 structural demand is mechanically orthogonal to every active macro variable. Rate hike fears, Warsh uncertainty, and growth multiple compression have no linkage to Eli Lilly's earnings trajectory. This remains the highest-conviction anchor.

XLV held at 10%. The sector fell 1.46% and now sits exactly at SMA20 ($150.71). The defensive anchor's earnings durability and dividend characteristics earn their weight precisely when rate policy introduces economic uncertainty. Healthcare's non-cyclical revenue streams and pricing power are most valuable in environments where the rate path is opaque and growth outcomes are less certain. A sustained close below SMA20 would require reassessment.

NVDA held at 5%. The stock deepened below SMA20 to $204.65 vs. $212.43. However, the AI infrastructure demand thesis received a meaningful structural signal today: the CEOs of Anthropic and Google DeepMind called for a US-led AI coalition at the G7, confirming that AI compute spending is now a geopolitical priority, not merely a corporate capex decision. The half-position is maintained at minimum conviction size. Reclaiming SMA20 is the condition for any weight increase.

Institutional Context

Bridgewater's combined S&P 500 exposure (SPY 12.7% + IVV 10.7%) means the firm absorbs today's SPY SMA20 break with relatively little single-stock selection buffer — a structural reason why this portfolio maintains meaningful idiosyncratic positions in LLY and JPM rather than concentrating in broad indices. Berkshire Hathaway's 22% AAPL concentration and absence from the candidate universe reflects a different time-horizon mandate: Buffett's holding company tolerates illiquidity and operates on multi-year conviction. Pershing Square's 15.3% MSFT allocation (-3.79% today, momentum20 -8.75%) confirms that even the most concentrated macro investors are absorbing real pain in the tech pivot — validating the decision to trim rather than hold the full tech weight through this regime shift.

Scion's November 2025 filing showing 66% Palantir concentration is noted as the most contrarian institutional signal: government AI infrastructure over consumer tech, which rhymes directionally with the G7 AI coalition push today, though Palantir is outside the candidate universe.

Thesis Risks

Primary risk — Warsh task force opacity. CNBC analysis identifies Warsh's task forces as the key to understanding the new Fed. If the reviews conclude that structural reassessment is needed before any policy pivot, the higher-for-longer duration extends significantly beyond current pricing. This would require further trimming of rate-sensitive growth exposure even at the cost of abandoning strong 60-day momentum readings.

Secondary risk — XLV at SMA20. Healthcare sitting exactly at its 20-day moving average is a binary technical event for the next session. A sustained break below would signal that the defensive anchor is no longer providing the portfolio insurance it was positioned to deliver and would require a trim or exit.

Upside scenario — Rate shock absorbed. If growth data proves resilient and the market concludes that Warsh is signaling institutional discipline without actually hiking, JPM's NIM expansion thesis compounds further, XLK's outstanding momentum resumes its trend, and QQQ recovers above SMA20. The portfolio's 15% JPM weight is sized for this asymmetry — the position benefits most directly if the higher-for-longer thesis plays out, and retains meaningful tech exposure if the regime reverts.